Marshall University

Marshall Digital Scholar
Management Faculty Research

Management, Marketing and MIS

11-1-2004

Comparative Cost Analysis of CRRT in ICU/
CCU Patients Undergoing Cardiovascular Surgery
vs. Other Procedures at a Texas Hospital
Tejaswi Belavadi
Alberto Coustasse
Marshall University, coustassehen@marshall.edu

Douglas Mains
Antonio A. Rene

Follow this and additional works at: http://mds.marshall.edu/mgmt_faculty
Part of the Business Administration, Management, and Operations Commons, Health and
Medical Administration Commons, and the Health Services Administration Commons
Recommended Citation
Belavadi T., Coustasse, A., Mains, D., Rene, A. Comparative cost analysis of CRRT in ICU/CCU patients undergoing cardiovascular
surgery vs. other procedures at a Texas hospital. American Public Health Association Annual Meeting, Washington, D.C. Nov. 2004.

This Conference Proceeding is brought to you for free and open access by the Management, Marketing and MIS at Marshall Digital Scholar. It has been
accepted for inclusion in Management Faculty Research by an authorized administrator of Marshall Digital Scholar. For more information, please
contact zhangj@marshall.edu.

Comparative Cost Analysis of CRRT in ICU/CCU Patients Undergoing
Cardiovascular Surgery Vs. Other Procedures at a Texas Hospital
University of North Texas Health Science Center School of Public Health
Tejaswi Belavadi, MBBS, MPH., Alberto Coustasse, MD, MBA, Dr.PH.,
Douglas Mains, Dr.PH., Antonio A. Rene., PhD, MPH.

ABSTRACT
The purpose of this study was to conduct a comparative analysis of hospital
costs incurred by patients undergoing Cardiovascular Surgery (CVS) and
patients undergoing other medical procedures who received Continuous
Renal Replacement Therapy (CRRT) in a teaching hospital. A total of 117
patients were identified through review of medical charts for the period of
January 1999 to August 2002. Twenty one percent of them were identified
having CVS. Eighty-eight percent of the CVS patients admitted to the ICU for
CRRT died compared to 67% for non-CVS patients (p=0.047). Average actual
costs of hospitalization were $47,225 for CVS patients and $51,724 for nonCVS patients. The mean length of stay (LOS) was 12.8 days for the CVS
patients and 18.1 days for other patients (p=0.03). Mean LOS for patients who
survived was 23.1 days whereas the average LOS for patients who died was
14.5 days (p=0.06). The differences found between patients who had CVS with
CRRT as compared to non-CVS patients with CRRT in terms of mortality and
length of stay raise ethical as well cost effectiveness questions of the
procedure.

Costs and payments using CRRT during hospitalization

RESULTS
Characteristics of patients undergoing CRRT at the ICU
Characteristic

Number

Percent

Age group
< 65
>65

47
70

40.2
59.8

Gender
Female
Male

66
51

56.4
43.6

Procedure
CV
Surgery w
or w/o
other
surgery

69
31
16
1
117

Total
CRRT
patients

Hospital
Costs
Mean

Race
White non Hispanics
Black non Hispanics
Hispanics
Other
Total

Non-CV
Surgery cases

$47,225

$51,724

$55,763

Payments
Received

59
26.5
13.7
0.8
100

Mean

$28,795

$33,786

$32,720

Total
Profit (loss)

$(460,762)

$(1,650,276)

$(2,111,038)

GOALS

Patients with CRRT at the ICU. Type of Procedure.

• To conduct a comparative analysis of estimated hospital costs of a
population of patients who have undergone CRRT.
• To perform comparative analysis between patients with
cardiovascular surgery (CVS), patients with other surgeries and
patients with no surgery at the ICU.

Type of procedure

n

%

CVS

19

16.2

CONCLUSION

CVS with another surgery

6

5.1

Medical Cases with another
Surgery

48

41.0

Medical cases no surgery

44

37.6

Total

117

100%

•Based on the results of this analysis, we conclude that
among patients undergoing CRRT, increased costs are incurred
for patients <65 years old that undergo surgery and who do not
expire in the hospital.
•Being a female <65 years old is associated with leaving the
hospital alive.
•There is greater risk for male patients 65 years or older to
expire.
•Patients undergoing CVS also have a greater risk of expiring in
the hospital.
•These characteristics lend themselves more difficult cost
benefit questions that involve ethical and economic decisions.

INTRODUCTION
• Renal failure is recognized as a common complication of patients
admitted to the Intensive Care Unit (ICU).
• This study describes the clinical characteristics and examines
hospital costs involved in the care of 117 patients undergoing
Continuous Renal Replacement Therapy (CRRT).
• End of Life decisions regarding the withdrawal, withholding of life
supporting and futile care have become commonplace within the
ICUs.

CRRT at the ICU: Discharge status
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METHODS
• Retrospective review of clinical and cost data from patient discharged
between 01/01/99 to 08/31/02 (3 fiscal years).
• Main inclusion criteria: Patients undergoing CRRT at the ICU for any
diagnosis or disease.
• Variables: Gender, age group, race/ethnicity, CVS surgery, other
surgeries, non surgical, length of stay, estimated costs, actual
payments, profit (loss) and hospital discharge status.
• Freidman's cost to charge ratio of 33% was used to estimate cost.

83.3
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70.0
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68.8
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DISCUSSION
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•Efforts to prolonging life once considered an outcome of
healing may be viewed by some as harmful acts of prolonging
suffering.
•The costs of futile care for the dying are enormous. Futility can
present challenges because of the monetary cost of such care,
its negative effect on staff members and the burden it creates
on the patient family and the clinicians .

